<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02159378</url>
  </required_header>
  <id_info>
    <org_study_id>CHD008-14</org_study_id>
    <nct_id>NCT02159378</nct_id>
  </id_info>
  <brief_title>Fructosamines and Gestational Diabetes (FRUCTO)</brief_title>
  <acronym>FRUCTO</acronym>
  <official_title>Fructosamines and Gestational Diabetes (FRUCTO)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Departemental Vendee</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Departemental Vendee</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The prevalence of gestational diabetes is estimated at between 2 and 6%, but can be much
      higher in specific populations.

      The specific treatment of gestational diabetes (diet, control weight gain, self monitoring
      glucose , insulin therapy) reduces complications severe perinatal, fetal macrosomia, and
      preeclampsia compared with abstention therapy, without additional risk of caesarean section.

      Several early studies have shown that the determination of fructosamine is a very bad way of
      diagnosis for Gestational Diabetes. However, few studies have investigated the relationship
      between the determination of serum fructosamine and put under insulin in case of Gestational
      Diabetes.

      The purpose of this study is to determine if serum fructosamines rate can be a predictive
      marker of the starting insulin at the patients suffering from Gestational Diabetes
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2014</start_date>
  <completion_date type="Actual">March 2016</completion_date>
  <primary_completion_date type="Actual">September 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Serum fructosamine rate</measure>
    <time_frame>at baseline (when gestational diabetes is diagnosed: between 24 and 28 weeks of gestation or later)</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">200</enrollment>
  <condition>Pregnancy</condition>
  <condition>Gestational Diabetes</condition>
  <arm_group>
    <arm_group_label>GD with Insulin treatment</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>At the end of the study patients will be divided into two groups: &quot;GD with Insulin treatment&quot; versus &quot;GD without Insulin treatment&quot; In each group, the serum fructosamines rate will be estimated with a confidence interval of 95% and compared from a Student test.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>GD without Insulin treatment</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>At the end of the study patients will be divided into two groups: &quot;GD with Insulin treatment&quot; versus &quot;GD without Insulin treatment&quot; In each group, the serum fructosamines rate will be estimated with a confidence interval of 95% and compared from a Student test.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Fructosamines</intervention_name>
    <arm_group_label>GD with Insulin treatment</arm_group_label>
    <arm_group_label>GD without Insulin treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age ≥18 years

          -  Ongoing pregnancy with a start date of pregnancy known and confirmed by an ultrasound
             of the 1st Quarter performed between 10 and 14 weeks with measurement of the
             crown-rump length

          -  Hospitalization for a GD's discovery whatever the term of pregnancy (GD is defined
             with nationals recommendations of CNGOF)

          -  Not opposed to participate in the study

        Exclusion Criteria:

          -  Pregnancy uncertain term (absence of early ultrasound)

          -  Previous diabetes to the pregnancy (type 1 or 2)

          -  Multiple Pregnancy

          -  No affiliation to a social security scheme

          -  Woman with a measure of legal protection
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Guillaume DUCARME, PH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Départemental Vendée</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre hospitalier départemental Vendée</name>
      <address>
        <city>La Roche sur Yon</city>
        <zip>85925</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 6, 2014</study_first_submitted>
  <study_first_submitted_qc>June 6, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 9, 2014</study_first_posted>
  <last_update_submitted>September 27, 2016</last_update_submitted>
  <last_update_submitted_qc>September 27, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 28, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Gestational Diabetes</keyword>
  <keyword>Fructosamines</keyword>
  <keyword>Insulin treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes, Gestational</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin, Globin Zinc</mesh_term>
    <mesh_term>Insulin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

